SPLENIC METASTASIS IN HAIRY-CELL LEUKEMIA

被引:0
作者
SHARPE, RW [1 ]
RECTOR, JT [1 ]
RUSHIN, JM [1 ]
GARVIN, DF [1 ]
COTELINGAM, JD [1 ]
机构
[1] NATL NAVAL MED CTR, DEPT LAB MED, BETHESDA, MD 20814 USA
关键词
PROSTATIC NEOPLASM; UNKNOWN PRIMARY NEOPLASM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC ACID PHOSPHATASE ANTIGEN; SPLENIC METASTASIS; HAIRY CELL LEUKEMIA; NATURAL KILLER CELLS;
D O I
10.1002/1097-0142(19930401)71:7<2222::AID-CNCR2820710710>3.0.CO;2-B
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Splenic metastasis is uncommon and usually occurs in the setting of widespread visceral metastasis. Splenic metastasis as an initial manifestation of disease and sole site of metastasis has not been reported previously. Methods. The authors describe a patient with hairy cell leukemia (HCL) with the unexpected finding of metastatic adenocarcinoma in the spleen. Direct inspection at the time of laparotomy and subsequent radiographic studies did not show a primary or additional metastatic tumor. Eventually, he manifested evidence of pulmonary and hepatic metastases and died with fungal sepsis. Results. The splenectomy specimen showed HCL and metastatic adenocarcinoma. Immunohistochemical studies showed adenocarcinoma with diffuse cytoplasmic staining for prostate-specific antigen and focally positive results with prostatic acid phosphatase antigen. Postmortem examination 9 months later showed HCL and widespread metastatic adenocarcinoma. No primary tumor was identified, and multiple tissue blocks of the prostate had negative findings for tumor. Conclusions. The immunohistologic features of the metastatic adenocarcinoma were interpreted as prostatic in origin. The pattern of isolated metastatic disease in the absence of primary tumor appears to represent another possible atypical disease presentation of prostatic cancer. Hairy cell-induced structural and immunologic alterations within the splenic microenvironment may have contributed to this unique clinical presentation.
引用
收藏
页码:2222 / 2226
页数:5
相关论文
共 51 条
[21]  
KLEIN B, 1987, CANCER, V60, P100, DOI 10.1002/1097-0142(19870701)60:1<100::AID-CNCR2820600118>3.0.CO
[22]  
2-9
[23]   IMMUNOSUPPRESSIVE EFFECTS OF PENTOSTATIN [J].
KRAUT, EH ;
NEFF, JC ;
BOURONCLE, BA ;
GOCHNOUR, D ;
GREVER, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :848-855
[24]   CHARACTERIZATION OF LYMPHOCYTE-T SUBSETS IN HAIRY-CELL LEUKEMIA (HCL) BY MONOCLONAL-ANTIBODIES - COMPARISON WITH FC-GAMMA-RECEPTORS, FC-MU-RECEPTORS AND CORRELATION WITH DISEASE-ACTIVITY [J].
LAURIA, F ;
FOA, R ;
GOBBI, M ;
PULVIRENTI, A ;
RASPADORI, D ;
GIUBELLINO, MC ;
TURA, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 52 (04) :657-662
[25]  
LAURIA F, 1984, SEMIN ONCOL, V11, P409
[26]   MULTIPLE NEOPLASMS IN HAIRY-CELL LEUKEMIA [J].
LAWLOR, E ;
WILLOUGHBY, R ;
OBRIAIN, DS ;
DALY, PA .
ACTA HAEMATOLOGICA, 1984, 72 (01) :57-60
[27]  
MARYMONT JH, 1963, AM J CLIN PATHOL, V40, P58
[28]   PROSTATE-CANCER WITH SOLITARY PAROTID METASTASIS CORRECTLY DIAGNOSED WITH IMMUNOHISTOCHEMICAL STAINS [J].
MOUL, JW ;
PAULSON, DF ;
FULLER, G ;
GOTTFRIED, MR ;
FLOYD, WL .
JOURNAL OF UROLOGY, 1989, 142 (05) :1328-1329
[29]  
NANBA K, 1977, AM J CLIN PATHOL, V67, P415
[30]   HAIRY-CELL LEUKEMIA ASSOCIATED WITH CARCINOMA - REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE [J].
OR, R ;
RAZ, I ;
POLLIACK, A .
BLUT, 1985, 50 (05) :299-301